News and events
What are the symptoms of Parkinson’s disease?
There are many different symptoms associated with Parkinson's disease and the order in which these develop and their severity is different for each individual. Usually, the symptoms start mildly and develop gradually. Parkinson's disease symptoms are distinguished between motor symptoms and non-motor symptoms.
Meet us at the 10th Congress of the European Academy of Neurology
Meet us at the 10th Congress of the European Academy of Neurology to learn more about our data-driven approach to managing Parkinson’s disease, and how it will help people with Parkinson’s to get the best treatment possible – improving their quality of life!
10x health technology from Finland
Tekniikan Maailma features ten Finnish health technology companies providing innovative solutions for the benefit of the patient – Adamant Health with its unique measurement and analysis service for Parkinson's disease being one of them.
What is Parkinson’s disease?
Parkinson’s disease is a progressive neurological disorder that is caused by the degeneration of nerve cells in the part of the brain called the substantia nigra, which controls movement, resulting in tremors, slowness of movement, rigidity, and impaired balance and coordination – the primary symptoms of the disease.
Benefits of objectively measuring Parkinson’s disease motor symptoms
The gold standard for evaluating Parkinson’s disease symptoms has primarily relied on subjective assessments during in-clinic visits using rating scales like the Unified Parkinson’s Disease Rating Scale (UPDRS). This approach, however, has specific limitations, leading to often incomplete disease progression evaluation. Over the last decades, various methods have been developed to assess the patients' motor symptoms more accurately.
World Parkinson's Day 2024
Today is World Parkinson's Day, a day dedicated to raising awareness for the disease and paying tribute to people living with the condition every day! Parkinson’s disease is the fastest-growing neurological disorder in the world, affecting people of all races and cultures.
Parkinson's Awareness Month 2024
April marks Parkinson’s Awareness Month, a time dedicated to increasing awareness about and elevating the conversation around Parkinson's disease, a neurological disorder that progressively impairs movement and function, affecting millions worldwide.
Digital solutions for the benefit of patients
The Paracelsus Nordseeklinik Helgoland's specialist neurological department, headed by Dr. Annette Rogge, offers a multimodal therapy program for patients with Parkinson's disease. To provide her patients with the best possible treatment tailored to their individual disease progression, Dr. Rogge opted for an objective assessment of motor symptoms using the measurement and analysis services provided by Adamant Health.
Bringing research to the benefit of people suffering from Parkinson’s disease
On Saturday, we had the honor to celebrate the Finnish Movement Disorders Association’s 40th anniversary together with over 200 guests, including people diagnosed with movement disorders and their relatives.
Improving the dialog between patients and clinicians through detailed symptom data
With the current practice of treating patients with Parkinson’s disease through in-person clinical examination, clinicians have only a limited amount of time available for observing and examining the patients and are heavily relying on patient reporting for symptoms and overall well-being.
Meet us at the 22nd Annual Scandinavian Meeting on Parkinson’s Disease and Related Disorders
Adamant Health is participating in the 22nd Annual Scandinavian Meeting on Parkinson’s Disease and Related Disorders taking place from 26–27 April 2024 in Helsinki, Finland. Meet us at our booth to learn more about how our technology can help you make more informed treatment decisions for your Parkinson's patients!
Meet us at the Deutscher Kongress für Parkinson und Bewegungsstörungen 2024
Adamant Health is participating in the Deutscher Kongress für Parkinson und Bewegungsstörungen 2024 taking place from 25 to 27 April 2024 in Rostock, Germany. Meet us at our booth to learn more about our data-driven approach for managing Parkinson’s disease!
Bringing data-driven management for Parkinson’s disease to Germany
The DGN-Kongress in Berlin was the venue for this year’s annual meeting of the German Neurological Society from November 8 to 11, 2023. Launching its presence in Germany, Adamant Health participated for the first time as an advanced technology provider with a booth to promote our concept for accurate and detailed symptom measurement.
World Movement Disorders Day 2023
Movement disorders can be especially difficult to diagnose, treat, and understand. In the next 30 years, there will be a strong increase in the number of people affected by movement disorders and that is why we are promoting #MoveDisorder awareness.
The role of EMG and kinematic measurements for objective symptom evaluation
Parkinson’s disease is a neurodegenerative disease without any curative treatment or neuroprotective or disease-halting drugs. It is characterized by motor symptoms that are still quantified mostly by subjective methods. Studies have shown that combining surface electromyography (EMG) and kinematic measurements can lead to objective quantification of a patient’s neuromuscular and motor function.
Meet us at the Neurologipäivät 2023
Meet us at the Neurologipäivät 2023 to learn more about our data-driven approach for managing Parkinson’s disease, and how it will help people with Parkinson’s to get the best treatment possible – improving their quality of life!
Meet us at the 96. Kongress der Deutschen Gesellschaft für Neurologie
Adamant Health is participating in the 96. Kongress der Deutschen Gesellschaft für Neurologie taking place from 8 to 11 November 2023 in Berlin, Germany. Meet us at booth B17 to learn more about our data-driven approach for managing Parkinson’s disease!
Adding technology to tradition: the new gold standard for assessing Parkinson’s disease
We’ve just returned from this year’s International Congress of Parkinson’s Disease and Movement Disorders in Copenhagen and are strongly encouraged by the valuable and in-depth discussions we had there. We feel it is absolutely key to continue educating the market about the EMG signal’s role in quantifying the neurophysiological basis of motor symptoms and why it provides a more accurate picture.
Adamant Health has developed a unique method for measuring the symptoms of Parkinson's patients
Adamant Health has developed a technology and service that will revolutionize the care of Parkinson's disease and other movement disorders. Business Kuopio has interviewed Adamant Health's founders Paulus Carpelan and Saara Rissanen.
Meet us at the International Congress of Parkinson's Disease and Movement Disorders 2023
Adamant Health is participating in the International Congress of Parkinson's Disease and Movement Disorders taking place from 27 to 31 August 2023 in Copenhagen, Denmark. Meet us at booth C3-262 to learn more about our data-driven approach!